Matthew P. Young
CIK 1601583 · EVP & CFO · last filed 2026-06-22
Matthew P. Young is an EVP & CFO who has filed 49 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for CTMX, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$3.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.16M
3
49
-$3.55M
Holdings By Company
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2021-07-01 | PRA Health Sciences, Inc. (PRAH) Delisted | Disp (D) | −7,127 | $0 | EDGAR |
| 2021-06-17 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2021-06-03 | PRA Health Sciences, Inc. (PRAH) Delisted | Grant (A) | +250 | $0 | EDGAR |
| 2020-06-17 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2020-05-20 | PRA Health Sciences, Inc. (PRAH) Delisted | Grant (A) | +1,324 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.